Searches were performed across four databases: China National Knowledge Infrastructure (CNKI), PubMed, Web of Science, and Embase, covering publications from January 2015 to December 2025. Language restrictions were applied: English for PubMed, Web of Science, and Embase; Chinese and English for CNKI.

(("hepatectomy"[Title/Abstract] OR "liver resection"[Title/Abstract] OR "hepatic resection"[Title/Abstract]) AND ("prognostic nutritional index"[Title/Abstract] OR "PNI"[Title/Abstract] OR "controlling nutritional status"[Title/Abstract] OR "CONUT"[Title/Abstract] OR "nutritional risk index"[Title/Abstract] OR "NRI"[Title/Abstract] OR "geriatric nutritional risk index"[Title/Abstract] OR "GNRI"[Title/Abstract] OR "hemoglobin-albumin-lymphocyte-platelet score"[Title/Abstract] OR "HALP"[Title/Abstract] OR "Naples prognostic score"[Title/Abstract] OR "NPS"[Title/Abstract] OR "sarcopenia"[Title/Abstract] OR "textbook outcome"[Title/Abstract] OR "post-hepatectomy liver failure"[Title/Abstract])).

Equivalent adapted search syntax was used for Web of Science, Embase, and CNKI. Classic landmark publications (e.g., the original PNI validation study) were additionally identified through citation chasing.

A total of 4286 records were initially identified across all databases. After deduplication, 2612 unique records remained for title and abstract screening. Of these, 2147 records were excluded based on eligibility criteria, leaving 465 full-text articles for full-text assessment. After full-text review, 112 studies met all inclusion criteria and were included in the final scoping review synthesis.

Eligible study types included randomized controlled trials (RCTs), prospective cohort studies, retrospective cohort studies, case-control studies, systematic reviews, and meta-analyses. Inclusion criteria were: 1) study participants were patients who underwent hepatectomy; 2) the study assessed the relationship between preoperative nutritional status or nutritional scores and perioperative outcomes or long-term prognosis; 3) outcome measures included at least one of the following: postoperative complications, PHLF, length of hospital stay, RFS, OS, or TO; 4) studies with complete data were eligible. Exclusion criteria were: 1) duplicate publications; 2) conference abstracts, case reports, expert opinions, and editorials; 3) studies with incomplete data or data that could not be extracted. The screening process was conducted independently by two researchers, and any disagreements were resolved through discussion or adjudication by a third reviewer.

The NRS-2002 is a nutritional risk screening tool recommended by the European Society for Clinical Nutrition and Metabolism (ESPEN). It consists of three components: the Impaired Nutritional Status score (0 - 3 points), the Disease Severity score (0 - 3 points), and an age adjustment (1 point for patients aged ≥ 70 years). A total score of ≥3 indicates nutritional risk. The NRS-2002 is easy to administer and widely applicable, making it a practical tool for nutritional risk screening at admission in patients undergoing liver resection. Multiple studies have shown that an NRS-2002 score of ≥3 is significantly associated with a higher incidence of postoperative complications and prolonged hospital stay after liver resection [6][13]. However, because the NRS-2002 primarily reflects nutritional risk rather than providing a detailed characterization of nutritional status, its predictive accuracy is limited. It should therefore be used in conjunction with other nutritional assessment tools.

The PNI was first proposed by Onodera et al. in 1984, and its calculation formula is: [Formula editable via MathType: PNI = serum albumin (g/L) + 5 × lymphocyte count (×10⁹/L)]. This index reflects both nutritional reserves (albumin) and immune status (lymphocyte count). Originally used to assess perioperative risk in patients undergoing gastrointestinal surgery, it is now widely applied in the prognostic evaluation of various malignant tumors [14].

Among nutritional scoring systems used in liver resection, the PNI currently has one of the strongest evidence bases. A meta-analysis by Zhang et al., including 19 studies and 9,830 patients with HCC, showed that compared with the high-PNI reference group, patients with low PNI had significantly worse OS (HR = 1.60, 95% CI: 1.44 - 1.77, p < 0.001) and RFS (HR = 1.48, 95% CI: 1.30 - 1.69, p < 0.001) [5]. A retrospective cohort study and meta-analysis by Fan et al. similarly confirmed that low PNI (<45) is an independent risk factor for OS and RFS in HCC patients following liver resection [15]. Regarding ICC, a multicenter retrospective study by Matsuda et al. found that a PNI < 50 was independently associated with severe complications (Clavien-Dindo grades III - V) (OR = 2.22, p = 0.013), and infectious complications were significantly more common in the low-PNI group (14.9% vs. 3.5%, p = 0.0021) [16]. A study by Tsukagoshi et al. further demonstrated that a PNI < 45 is significantly associated with early postoperative recurrence of HCC and the pattern of extrahepatic recurrence [4].

It is worth noting that the cutoff for PNI varies considerably in the literature, ranging from 40 to 50 (Fan et al. used 45; Matsuda et al. used 50; Sim et al. used 44) [15]-[17]. This heterogeneity may be related to differences in baseline characteristics, etiological composition, and sample size among different study populations; currently, there is still no universally accepted cutoff. Furthermore, Peng et al. found that changes in PNI after surgery (ΔPNI), rather than the absolute preoperative PNI value, were independent predictors of OS and RFS in patients with small HCC [18], suggesting that dynamic monitoring of perioperative nutritional status may offer prognostic value beyond a single baseline assessment.

The CONUT score is based on three parameters: serum albumin, lymphocyte count, and total cholesterol level, and was originally developed to screen for nutritional status in hospitalized patients. In recent years, multiple studies have confirmed the important value of the CONUT score in assessing outcomes after liver resection. Li et al. found in 1334 HCC patients that the early postoperative CONUT score was significantly associated with Clavien-Dindo grades III - V complications [19]. Wang et al. compared the prognostic performance of ALBI, CONUT, PNI, and CT-based nutritional indices in patients with iCCA and found that CONUT was significantly associated with both postoperative complications and overall survival (OS) [20].

The NRI is calculated based on serum albumin and percentage change in body weight, while the GNRI is a modified version of the NRI designed for older adults. Qin et al. found an interaction between the ALBI score and the NRI, and that combining the two improves prediction of PHLF [2]. Tsukagoshi et al. found in 203 patients with HCC that a low GNRI (<98) and a low PNI (<45) were both significantly associated with poorer OS and RFS, and that the GNRI was significantly associated with body composition (BMI, skeletal muscle index), liver function (Child-Pugh score), and tumor factors (tumor size, microvascular invasion) [4]. Qin et al. conducted a large-scale analysis of 1666 HCC patients, further supporting the prognostic value of GNRI and PNI for survival outcomes: A high GNRI (HR = 0.77, 95% CI: 0.70 - 0.85, p < 0.001) and a high PNI (HR = 0.77, 95% CI: 0.70 - 0.86, p < 0.001) were each independently associated with a lower risk of death, and the combined use of GNRI and PNI further improved prognostic performance [21].

In the field of ICC, a study by Wang et al. involving 157 older patients with ICC showed that low GNRI, sarcopenia, increased visceral fat, and intramuscular fat deposition were independent risk factors for OS and RFS. A nomogram based on GNRI and body composition indices showed better predictive performance than traditional TNM staging (C-index: OS 0.734, RFS 0.704) [22].

The HALP score integrates four parameters—hemoglobin, albumin, lymphocyte count, and platelet count—to reflect a patient’s oxygen-carrying capacity, nutritional reserves, immune function, and coagulation status. A meta-analysis by Zhang et al. confirmed that the HALP score has significant prognostic value for patients undergoing hepatectomy for primary liver cancer [23]. Compared with the PNI and CONUT, the HALP score has the advantage of including hemoglobin and platelet counts, thereby providing a more comprehensive assessment of systemic status.

The NPS is a relatively new immunonutritional scoring system that combines four indicators—serum albumin, total cholesterol, the neutrophil-to-lymphocyte ratio (NLR), and the lymphocyte-to-monocyte ratio (LMR)—to capture both nutritional status and systemic inflammation. Xie et al. conducted the first systematic evaluation of the prognostic value of the NPS in 476 patients with HCC undergoing liver resection. The results showed that NPS was an independent risk factor for OS (NPS group 3 vs. 1: HR = 2.608, 95% CI: 1.358 - 5.008, p = 0.004) and RFS (NPS group 3 vs. 1: HR = 2.002, 95% CI: 1.262 - 3.175, p = 0.003), and that its discriminatory prognostic performance (median AUC, 0.675) was superior to that of traditional scoring systems such as PNI and CONUT [24]. The NPS therefore provides a new option for preoperative risk assessment in liver resection; however, the available evidence remains limited and requires further validation in multicenter studies.

The GLIM criteria are a consensus framework for the diagnosis of malnutrition jointly published in 2018 by major international clinical nutrition societies. They comprise two dimensions: phenotypic criteria (unintentional weight loss, low BMI, reduced muscle mass) and etiological criteria (reduced food intake or malabsorption, inflammation/disease burden). A diagnosis of malnutrition requires fulfillment of at least one phenotypic criterion and one etiological criterion. A prospective observational study by Toutouzas et al. preliminarily evaluated the predictive value of the GLIM criteria for postoperative complications and mortality in patients with hepatopancreatobiliary (HPB) cancers [10]. Combining the GLIM criteria with traditional nutritional scoring is expected to further enhance the standardization and international comparability of preoperative nutritional assessment.

Each rating method has its own advantages and limitations, along with its respective application scenarios, as detailed in Table 1.

Table 1.Comparison of common preoperative nutritional assessment tools.

Note: Table is fully editable; all abbreviations are defined in the text.

The liver is a vital immune-regulatory organ in the body, and patients with liver disease often exhibit dysregulation of both innate and adaptive immune functions. Lymphocyte counts in the PNI, CONUT, GNRI, and NPS scores are key indicators of cellular immune function. Preoperative lymphocytopenia suggests weakened T-cell-mediated antitumor immune surveillance, which facilitates the survival and progression of postoperative micrometastases [25][29]. Furthermore, albumin is not only a marker of nutritional reserves but also contributes to maintaining the stability of immune cell membranes and facilitating cytokine transport. Surgical trauma from liver resection can further exacerbate the postoperative immunosuppressed state, whereas patients with good preoperative nutritional status are better able to maintain postoperative immune homeostasis.

Chronic systemic inflammation is considered an important driver of adverse outcomes after liver resection [30]. A bidirectional vicious cycle may occur between malnutrition and inflammation: malnutrition can impair intestinal barrier function, promote bacterial translocation and endotoxemia, and thereby activate hepatic Kupffer cells to release pro-inflammatory factors (TNF-α and IL-6); conversely, persistent inflammation can accelerate protein catabolism and inhibit hepatic albumin synthesis, further exacerbating malnutrition. A study by Wang et al. demonstrated that the systemic immune-inflammatory state represented by SII provides significant incremental predictive value for PHLF [1]. Utsumi et al. found that patients with sarcopenia had significantly higher NLR and lower AGR, suggesting a close association between muscle loss and systemic inflammation [26].

Proteins and albumin serve as the essential material foundation for collagen synthesis, tissue reconstruction, and immune defense. When patients are malnourished, insufficient protein reserves in the body can lead to delayed wound healing, reduced tissue repair capacity, and increased susceptibility to infection [13]. Hypoalbuminemia can also affect local microcirculation and tissue oxygen supply by reducing plasma colloid osmotic pressure, further delaying the wound healing process [31]. Therefore, maintaining good preoperative nutritional status is crucial for promoting postoperative tissue repair and reducing complications.

As the body’s central metabolic organ, the liver plays a central role in glucose metabolism, fatty acid oxidation, and protein synthesis [32]. Patients with liver disease often present with disorders of glucose and lipid metabolism as well as insulin resistance, and malnutrition can further deplete the body’s metabolic reserves, amplifying the perioperative stress response [17]. Chronic insulin resistance promotes hepatocyte proliferation and inhibits apoptosis via the insulin-like growth factor-1 (IGF-1) signaling pathway, and is closely associated with the onset, progression, and postoperative recurrence of HCC [33]. Improving nutritional status and the metabolic environment may help reduce the risk of postoperative recurrence by inhibiting the IGF-1 pathway and lowering levels of oxidative stress.

Skeletal muscle is not only a motor organ but also a major metabolic and immunoregulatory organ. Sarcopenia is widely recognized as one of the key factors influencing outcomes after liver resection [26][34]. A reduction in skeletal muscle mass is closely associated with an increased incidence of postoperative complications and reduced survival. The pathophysiological mechanisms involved include: 1) As a major reservoir of glutamine and branched-chain amino acids (BCAAs), skeletal muscle loss may reduce the substrates available for liver regeneration; 2) Reduced secretion of myokines, such as the anti-inflammatory factors irisin and IL-15, may weaken the ability of skeletal muscle to modulate systemic inflammation; 3) disruption of the “muscle-liver axis”, characterized by abnormal BCAA metabolism, hyperammonemia, and a vicious cycle of protein-energy wasting [22].

Studies have shown that sarcopenia and low PNI often coexist and may mutually contribute to poorer outcomes [35][36]. Wang et al. found that in elderly patients with ICC, a nomogram combining GNRI with skeletal muscle index (SMI), muscle atrophy, and visceral fat ratio showed significantly better predictive performance than TNM staging [22]. CT-measured skeletal muscle index (SMI) and psoas major index (PMI) have been demonstrated to be independent predictors of postoperative prognosis in patients with hepatocellular carcinoma [37]. Heil et al. found in 306 patients undergoing portal vein embolization (PVE) that sarcopenia predicted insufficient liver regrowth and reduced resection rates [34], while Baby et al. further confirmed the association between sarcopenia and limited regrowth of residual liver volume following PVE [36]. Therefore, combining traditional nutritional scores with indicators of sarcopenia may facilitate development of more precise perioperative risk-assessment models.

With continued advances in precision medicine, nutritional assessment has evolved from simple risk stratification into a tool that can support clinical decision-making. Existing evidence indicates that perioperative stratification based on nutritional scores may facilitate early identification of high-risk patients and delivery of individualized nutritional support, thereby reducing postoperative complications and promoting recovery; however, current data are predominantly observational and demonstrate only associations, not causal benefits of score-guided intervention [32][38].

Based on available observational evidence, we propose a provisional, expert-driven three-tiered assessment framework (not yet validated by prospective intervention trials): “NRS-2002 initial screening → PNI/CONUT in-depth assessment → supplementary evaluation for sarcopenia”. All patients scheduled for liver resection should undergo NRS-2002 screening within 24 hours of admission. Patients with an NRS-2002 score < 3 and a PNI > 45 are considered to have low nutritional risk and should receive routine perioperative dietary guidance and oral nutritional supplements (ONS), managed according to Enhanced Recovery After Surgery (ERAS) principles [13]. Patients with an NRS-2002 score ≥ 3 or a PNI ≤ 45 should undergo further assessment of nutritional status and hepatic reserve, including the CONUT score, GNRI, ALBI classification, and CT-based assessment of sarcopenia (SMI and PMI), to enable more precise risk stratification [39]. For patients with severe malnutrition—defined as weight loss of ≥10% within the past 6 months, BMI < 18.5 kg/m², serum albumin < 30 g/L, or concomitant sarcopenia—a multidisciplinary team (MDT) comprising hepatobiliary surgery, clinical nutrition, anesthesiology, and physical medicine and rehabilitation should be assembled for comprehensive evaluation. Preoperative nutritional optimization for 7 - 14 days should be considered, provided that this does not delay cancer treatment [19]. This process establishes a closed-loop management model of “screening → assessment → intervention → reassessment”.

Both the ESPEN and ERAS guidelines emphasize the importance of preoperative nutritional optimization. For patients at nutritional risk, enteral nutritional support should be prioritized, with recommended energy intake of 25 - 30 kcal/kg/day and protein intake of 1.2 - 1.5 g/kg/day; for patients with severe malnutrition or sarcopenia, protein intake may be increased to 1.5 - 2.0 g/kg/day [21]. Recent studies have shown that immunonutritional formulations containing omega-3 fatty acids, arginine, and nucleotides may enhance immune function and reduce the incidence of infection. For patients with low PNI or HALP scores, individualized perioperative immunonutritional support may be considered [23].

For patients with concomitant cirrhosis or portal hypertension, nutritional regimens should be adjusted according to liver function status: BCAA supplementation can improve protein metabolism and liver reserve capacity; patients with ascites require appropriate sodium restriction; and those with a history of hepatic encephalopathy protein intake should be increased cautiously [24][40]. Yokoyama et al. emphasized the importance of preoperative “muscle and intestine training”, which combines exercise training and bowel management with nutritional support [41].

Prehabilitation has emerged as an important focus of perioperative management in recent years; its core concept is to enhance stress tolerance by improving patients’ physiological reserves before surgery. For patients at high nutritional risk, a multimodal prehabilitation strategy combining nutritional support, exercise training, and psychological intervention is recommended. Nutritional intervention should focus on ensuring adequate protein and energy intake; exercise training should combine aerobic and resistance training; and psychological intervention may alleviate anxiety and depression while improving treatment adherence [42].

Existing studies indicate that multimodal prehabilitation can improve the preoperative functional status of patients undergoing liver resection, shorten hospital stays, and reduce the incidence of postoperative complications [43]. For patients with sarcopenia, prehabilitation may provide greater clinical benefits than nutritional support alone [44]. A systematic review and meta-analysis by Wagner et al. further confirmed that sarcopenia significantly impacts outcomes after liver resection in patients with colorectal liver metastases, highlighting the importance of preoperative screening and intervention for sarcopenia [44]. A study by Hayakawa et al. demonstrated that predictive models integrating surgical complexity and nutritional parameters can improve the accuracy of predicting postoperative complications [42].

Continuous advancements in body composition analysis technologies are shifting nutritional assessment from a single biochemical marker toward a comprehensive evaluation paradigm that encompasses nutrition, immunity, and muscle. Numerous studies have confirmed that sarcopenia is an independent risk factor affecting postoperative complications and long-term survival following liver resection [34]. SMI and PMI measured by CT have been shown to predict prognosis in patients with hepatocellular carcinoma and biliary tract tumors, and sarcopenia is significantly associated with nutritional scores such as PNI and GNRI, suggesting a synergistic effect between the two [36]. Future research should further explore the development of a multidimensional nutrition-immunity-muscle assessment system and investigate its predictive performance across different tumor types (HCC vs. ICC vs. metastatic liver cancer), varying liver function statuses, and different surgical approaches.

In recent years, machine learning and artificial intelligence technologies have advanced rapidly in the field of hepatobiliary surgery, providing a new framework for integrating multidimensional clinical features. Wang et al. developed six machine learning survival prediction models (including Gradient Boosting and Random Survival Forest) based on 290 iCCA patients, integrating blood-based nutritional indicators such as ALBI, CONUT, and PNI, as well as CT-based nutritional indicators such as SMI and VSR. Among these, the Gradient Boosting model showed the best performance (training set C-index: 0.755, validation set C-index: 0.714). Time-dependent ROC curves, calibration curves, and decision curve analyses all confirmed its clinical utility [20].

The nomogram developed by Xu et al. can predict recurrence and RFS in patients with unresectable HCC following treatment with lenvatinib, PD-1 inhibitors, and interventional therapy leading to conversion to resectable status [28]. The combination of radiomics and machine learning may enable noninvasive prediction of short- and long-term postoperative outcomes preoperatively, supporting personalized treatment decisions [45]. Mami et al. developed and validated cut-off values for sarcopenia in patients with gastrointestinal and HPB tumors based on the GLIM criteria [45]. In the future, multimodal fusion models (integrating clinical, laboratory, radiomics, and deep learning features) are expected to substantially outperform the predictive performance of traditional scoring systems.

Although numerous observational studies have confirmed that nutritional scores such as PNI, CONUT, GNRI, HALP, and NPS are closely associated with outcomes after liver resection, high-quality evidence from prospective intervention studies remains limited [16][44]. Most existing evidence comes from retrospective or systematic review studies, which is insufficient to determine whether preoperative interventions based on nutritional scores can significantly improve long-term survival outcomes. Multicenter randomized controlled trials are needed to determine the causal effects of nutritional optimization measures, such as preoperative immunonutrition, prehabilitation, and BCAA supplementation, on postoperative liver function recovery and survival outcomes.

Perioperative nutritional status undergoes dynamic changes. A study by Peng et al. demonstrated that a postoperative decline in PNI (rather than a preoperative low PNI) is an independent risk factor for OS and RFS in patients with small HCC [46]. This finding has important clinical implications: nutritional assessment should not be limited to a single preoperative time point but should extend throughout the entire perioperative period and into the postoperative follow-up phase. The MDT management model plays a crucial role in improving the prognosis of liver cancer patients, particularly in those undergoing complex liver resections or with biliary tract tumors [10]. In the future, efforts could be made to establish an MDT collaboration model comprising the Department of Nutrition, Hepatobiliary Surgery, Rehabilitation Medicine, and Medical Oncology to provide patients with continuous nutritional monitoring and intervention throughout the care cycle.

TO is an emerging comprehensive surgical quality evaluation indicator that has been increasingly applied in hepatobiliary surgery in recent years [47]. A systematic review by Sweigert et al. comprehensively summarized the current status of TO application in liver surgery [11], while Rashid et al. further compared TO attainment rates between staged and concurrent resection for the treatment of synchronous colorectal liver metastases [47]. Studies have shown that sarcopenia is significantly associated with failure to achieve TO, suggesting that body composition may influence overall perioperative quality. Nutritional status and inflammatory markers also affect the TO achievement rate, highlighting their potential value for comprehensive prognostic assessment [11]. Future research could incorporate indicators such as PNI, CONUT, NPS, and sarcopenia into TO prediction models to construct a more comprehensive surgical quality evaluation system.